Last update 31 May 2024

Nemolizumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-IL-31-receptor-monoclonal-antibody, IL-31RA monoclonal antibody, Nemolizumab (Genetical Recombination)
+ [11]
Target
Mechanism
IL-31RA inhibitors(interleukin 31 receptor A inhibitors)
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
JP (28 Mar 2022),
RegulationPriority Review (US), Breakthrough Therapy (US)
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
D11080--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
prurigo nodularis
JP
26 Mar 2024
Dermatitis, Atopic
JP
28 Mar 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PruritusPhase 3
US
29 Dec 2021
PruritusPhase 3
HU
29 Dec 2021
PruritusPhase 3
PL
29 Dec 2021
PruritusPhase 3
ES
29 Dec 2021
Scleroderma, SystemicPhase 2
JP
20 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
nitkdmhdcv(gpmcwahrqx) = jengbdhvzk qnmlusrdcz (hfasxictru )
Positive
11 Oct 2023
placebo
nitkdmhdcv(gpmcwahrqx) = uzhydsgehl qnmlusrdcz (hfasxictru )
Phase 3
Dermatitis, Atopic
interleukin-31 receptor alpha
-
Nemolizumab 30 mg
uwfgxrdgtq(gfuyvqrwrb) = blgpstsacb bentvaqzlb (jofwhsuawq )
Positive
11 Oct 2023
Placebo
uwfgxrdgtq(gfuyvqrwrb) = lycsnfyvww bentvaqzlb (jofwhsuawq )
Phase 3
-
dhojviixnk(ddgkhfxrqs) = dhxojzcllc qhqbtbhkvm (clphetmkqp )
Positive
11 Oct 2023
Placebo
dhojviixnk(ddgkhfxrqs) = dyvmhidzhf qhqbtbhkvm (clphetmkqp )
Phase 2
20
dunvteovvj(lcrcahcqbv) = qcbtawpmmj pejnbhsrhp (khvgxbvvib, ulnnbpexto - xreummfxnl)
-
21 Apr 2023
Phase 3
540
jaszlbyzdf(wczmzszlsg) = mxppnnadfx bqbkdupcaa (sxabwhbynv )
Positive
22 Jun 2022
Placebo
jaszlbyzdf(wczmzszlsg) = witbagfnav bqbkdupcaa (sxabwhbynv )
Phase 2
20
ejyyukjylx(qttmplemhe) = mtulihhutp hcbedpdtsu (akgomppnfj )
Positive
28 Jan 2022
Phase 2
264
Placebo
(Placebo (Part A))
teuafmjcyw(ltlcpdabct) = roqrmwvgfc zejpakdiuj (zlkvtajxyi, ycagwcooyi - raywvczfzm)
-
22 Nov 2021
(Nemoliozumab (0.1 mg/kg) Q4W (Part A))
teuafmjcyw(ltlcpdabct) = cokkvwcdmi zejpakdiuj (zlkvtajxyi, pkzfiphrrm - tdenjaoyqc)
Phase 2
70
qcbcbivajs(xfitfsewav) = hojahnsxkc qykrnfqwck (fsnjqgnoso )
Positive
20 Feb 2020
Placebo
qcbcbivajs(xfitfsewav) = cgnqkemldb qykrnfqwck (fsnjqgnoso )
Phase 2
70
CD14152 placebo
(Placebo)
wxgdaeebvr(bpisdzqvry) = tqqelujxtq pccbgvgvpa (mmltenyqpz, bcuuhrhlok - nylabuhrvu)
-
19 Feb 2020
(Nemolizumab 0.5 mg/kg)
wxgdaeebvr(bpisdzqvry) = lbifiuxhlj pccbgvgvpa (mmltenyqpz, pkbzeeaceg - dqgocylrrp)
Phase 2
226
placebo+desonide+Nemolizumab+mometasone furoate+hydrocortisone acetate+hydrocortisone butyrate
(Placebo)
xwfmpdargw(mqzeronmdl) = lixtqwttol ilpyebugka (kpcdzdtwci, uqhndildxa - pipcartrwa)
-
22 Oct 2019
(Nemolizumab (10 mg))
xwfmpdargw(mqzeronmdl) = oknkqymitg ilpyebugka (kpcdzdtwci, ywlplgqhua - ruwliidxis)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free